Nisha
Patel, DO
Assistant Research Physician
Dr. Nisha Patel is a Staff Hematopathologist in the Department of Laboratory Medicine at the NIH Clinical Center. She specializes in the diagnostic evaluation of blood and bone marrow disorders.
BS, University of the Sciences
DO, Philadelphia College of Osteopathic Medicine
Dr. Patel graduated medical school from Philadelphia College of Osteopathic Medicine. She then completed her residency training in Anatomic and Clinical Pathology at the University of Rochester Medical Center in Rochester, New York. Dr. Patel subsequently completed a fellowship in Hematopathology at the Cleveland Clinic and joined the National Institutes of Health in August 2019.
She is board certified in Anatomic and Clinical Pathology as well as Hematopathology by the American Board of Pathology.
- NIH Clinical Center CEO Award: 2021, 2022, and 2024
- Second Place Presentation: 38th Annual Research Day, University of Rochester Medical Center, 2018
- First Place Presentation: 36th Annual Research Day, University of Rochester Medical Center, 2016
- Strong Star Award: University of Rochester Medical Center, 2015 and 2016
- Louis A. Reber Memorial Research Award in Biochemistry: University of the Sciences, 2010
Patel N, Calvo KR. How I diagnose myeloid neoplasms with germline predisposition. Am J Clin Pathol. 2023 Oct 3;160(4):352-364.
Patel N, Slack GW, Bodo J, et al. Immune Escape Mechanisms in Intravascular Large B-Cell Lymphoma: A Molecular Cytogenetic and Immunohistochemical Study. Am J Clin Pathol. 2022;157(4):578-585.
Patel N, Dulau-Florea A, Calvo KR. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome. Semin Hematol. 2021;58(4):204-211.
Kazandjian D, Hill E, Dew A, Morrison C, Roswarski J, Korde N, Emanuel M, Petrosyan A, Bhutani M, Calvo KR, Dulau-Florea A, Kwok M, Lee MJ, Lee S, Lindenberg L, Mailankody S, Manasanch E, Maric I, Mena E, Patel N, Tageja N, Trepel JB, Turkbey B, Wang HW, Wang W, Yuan C, Zhang Y, Braylan R, Choyke P, Stetler-Stevenson M, Steinberg SM, Figg WD Sr, Roschewski M, Landgren O. Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial. JAMA Oncol. 2021;7(11):1678-1685.
Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK, Ferrada MA, Wu Z, Gutierrez-Rodrigues F, Lotter J, Wilson L, Hoffmann P, Cardona DO, Patel N, Dulau-Florea A, Kastner DL, Grayson PC, Beck DB, Young NS, Calvo KR. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1 Blood Adv. 2021;5(16):3203-3215.
Patel N, Durkin L, Bodo J, Hsi ED. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas. Am J Clin Pathol. 2020;153(5):646-655.
Patel N, Hoffman CM, Goldman BI, Bentley K, Burack WR, Evans AG. Green Inclusions in Neutrophils and Monocytes Are an Indicator of Acute Liver Injury and High Mortality. Acta Haematol. 2017;138(2):85-90.
Schmidt AE, Kirkley S, Patel N, et al. An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab. Transfusion. 2015;55(9):2292-2293.